Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00911781 · ClinicalTrials.gov registry record

Hemangioma Growth During the First 6 Months of Life

A clinical trial, sponsored by University of California, San Francisco.

Completed
Registry status
36
Enrollment target

NCT00911781 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 36 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00911781 has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
36 participants
Enrollment target

Study Summary

One of the most important and unique characteristics of infantile hemangiomas is their dramatic growth during early infancy. Most hemangiomas are either absent at birth or barely evident as a small scratch or bruise-like area. A recent study emphasized how early hemangioma growth occurs. In this study by 3 months of age, hemangiomas had reached 80% of their final size, and by 5 months of age, 80% had already stopped growing. Unfortunately the average age when most infants are seen by specialists is often at 5 months of age or later, a time when most growth is already completed. Researchers at the University of California, San Francisco, the Medical College of Wisconsin, and at the Mayo Clinic are interested in studying hemangioma growth at even earlier ages, before 3 months of age, which is before most patients are ever seen by dermatologists or other specialists. For this study are requesting that parents of children older than 3 months of age with hemangiomas send us a series of photographs of their child which demonstrates this early growth. Ideally the photographs would show your child (including the area of the hemangioma of course) at weekly or every other week intervals up until age least 3 to 6 months of age. This will probably not be difficult if the hemangioma is on the face but we would be interested in other body locations as well, if available. We are using these photographs to analyze early hemangioma growth patterns, to see if there is a period of especially rapid growth, and to help determine if there is a specific time before which specialty referral should occur. We are interested in all sizes of hemangiomas, from small to large. Of greatest importance is that the photos be at frequent intervals (every 1 to 2 weeks is ideal) and of sufficient quality to be able to evaluate the appearance of the hemangioma.

Interventions

  • OTHER No intervention

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2009-02
Est. Completion 2011-12

What the Registry Record Tells You About NCT00911781

The ClinicalTrials.gov registry entry for NCT00911781 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.

NCT00911781 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00911781 about?

NCT00911781 is a clinical study titled "Hemangioma Growth During the First 6 Months of Life". One of the most important and unique characteristics of infantile hemangiomas is their dramatic growth during early infancy. Most hemangiomas are either absent at birth or barely evident as a small scratch or bruise-like area. A recent study emphasized how early hemangioma growth occurs. In this stu...

What is the current status of trial NCT00911781?

This trial is currently completed. The enrollment target is 36 participants. The study started on 2009-02. Estimated completion is 2011-12.

What interventions are being tested in trial NCT00911781?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT00911781?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.